140 related articles for article (PubMed ID: 16080553)
1. Cyclooxygenase-2 expression in brain metastases.
Karim A; Fowler M; Jones L; Patwardhan R; Vannemreddy P; Mccarthy K; Nanda A
Anticancer Res; 2005; 25(4):2969-71. PubMed ID: 16080553
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
Milas I; Komaki R; Hachiya T; Bubb RS; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
Clin Cancer Res; 2003 Mar; 9(3):1070-6. PubMed ID: 12631609
[TBL] [Abstract][Full Text] [Related]
3. Differential cyclooxygenase-2 enzyme expression in radiosensitive versus radioresistant glioblastoma multiforme cell lines.
Karim A; McCarthy K; Jawahar A; Smith D; Willis B; Nanda A
Anticancer Res; 2005; 25(1B):675-9. PubMed ID: 15816645
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide synthase expression and enzymatic activity in human brain tumors.
Broholm H; Rubin I; Kruse A; Braendstrup O; Schmidt K; Skriver EB; Lauritzen M
Clin Neuropathol; 2003; 22(6):273-81. PubMed ID: 14672505
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors.
Ermert L; Dierkes C; Ermert M
Clin Cancer Res; 2003 May; 9(5):1604-10. PubMed ID: 12738712
[TBL] [Abstract][Full Text] [Related]
6. Significance of COX-2 expression in human renal cell carcinoma.
Tuna B; Yorukoglu K; Gurel D; Mungan U; Kirkali Z
Urology; 2004 Dec; 64(6):1116-20. PubMed ID: 15596182
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas.
Achiwa H; Yatabe Y; Hida T; Kuroishi T; Kozaki K; Nakamura S; Ogawa M; Sugiura T; Mitsudomi T; Takahashi T
Clin Cancer Res; 1999 May; 5(5):1001-5. PubMed ID: 10353732
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 expression and relationship to tumour progression in human renal cell carcinoma.
Hashimoto Y; Kondo Y; Kimura G; Matsuzawa I; Sato S; Ishizaki M; Imura N; Akimoto M; Hara S
Histopathology; 2004 Apr; 44(4):353-9. PubMed ID: 15049901
[TBL] [Abstract][Full Text] [Related]
9. Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma.
Rini BI; Weinberg V; Dunlap S; Elchinoff A; Yu N; Bok R; Simko J; Small EJ
Cancer; 2006 Feb; 106(3):566-75. PubMed ID: 16369983
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of cyclooxygenase-2 in breast cancer and ductal carcinoma in situ has no correlation with established prognostic markers.
Ranger GS; Jewell A; Thomas V; Mokbel K
J Surg Oncol; 2004 Nov; 88(2):100-3. PubMed ID: 15499599
[TBL] [Abstract][Full Text] [Related]
11. Elevated cyclooxygenase-2 expression correlates with distant metastases in breast cancer.
Ranger GS; Thomas V; Jewell A; Mokbel K
Anticancer Res; 2004; 24(4):2349-51. PubMed ID: 15330183
[TBL] [Abstract][Full Text] [Related]
12. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.
Roland IH; Yang WL; Yang DH; Daly MB; Ozols RF; Hamilton TC; Lynch HT; Godwin AK; Xu XX
Cancer; 2003 Dec; 98(12):2607-23. PubMed ID: 14669280
[TBL] [Abstract][Full Text] [Related]
13. [Effect of cyclooxygenase-2,and matrix metalloproteinase-2 expression on prognosis of lung cancer].
Zhang HZ; Lu ZQ; Xie DR; Li HG; Xiong LH; Zhang H; Chen XB
Ai Zheng; 2004 Oct; 23(10):1190-3. PubMed ID: 15473933
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclooxygenase-2, Fas and Fas ligand in pulmonary adenocarcinoma and atypical adenomatous hyperplasia.
Takigawa N; Ida M; Segawa Y; Nakata M; Mandai K; Kishino D; Fujiwara K; Saeki H; Takashima S; Eguchi K
Anticancer Res; 2003; 23(6D):5069-73. PubMed ID: 14981968
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase-2 in adenocarcinomas of the uterine cervix and its relation to angiogenesis and tumor growth.
Lee JS; Choi YD; Lee JH; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Kim HS; Min KW
Gynecol Oncol; 2004 Dec; 95(3):523-9. PubMed ID: 15581957
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclooxygenase-2 in malignant and benign breast tumors.
Watanabe O; Shimizu T; Imamura H; Kinoshita J; Utada Y; Okabe T; Kimura K; Hirano A; Yoshimatsu K; Aiba M; Ogawa K
Anticancer Res; 2003; 23(4):3215-21. PubMed ID: 12926055
[TBL] [Abstract][Full Text] [Related]
17. [Metastatic brain tumors].
Taddei GL; Moncini D; Raspollini MR; Mennonna P; Boddi V; Dini M; Buccoliero AM
Pathologica; 1999 Feb; 91(1):13-7. PubMed ID: 10396945
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium.
Shim V; Gauthier ML; Sudilovsky D; Mantei K; Chew KL; Moore DH; Cha I; Tlsty TD; Esserman LJ
Cancer Res; 2003 May; 63(10):2347-50. PubMed ID: 12750248
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma.
Erkinheimo TL; Sivula A; Lassus H; Heinonen M; Furneaux H; Haglund C; Butzow R; Ristimäki A
Gynecol Oncol; 2005 Oct; 99(1):14-9. PubMed ID: 16126263
[TBL] [Abstract][Full Text] [Related]
20. Study of cyclooxygenase-2 in renal cell carcinoma.
Yoshimura R; Matsuyama M; Kawahito Y; Tsuchida K; Kuratsukuri K; Takemoto Y; Mitsuhashi M; Sano H; Nakatani T
Int J Mol Med; 2004 Feb; 13(2):229-33. PubMed ID: 14719128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
